close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

Strona główna・Stock List・BeOne Medicines Ltd ADR
Search

BeOne Medicines Ltd ADR

Closed

SectorHealthcare

375.03 2.54

Strong Buy

Price update 17 lis 2025, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

365.73

Max

384.76

Key metrics

By Trading Economics

Income

31M

125M

Sales

97M

1.4B

Profit margin

8.84

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+6.9% upside

Market Stats

By TradingEconomics

Market Cap

22B

Previous open

372.49

Previous close

375.03

News Sentiment

By Acuity

50%

50%

152 / 374 Ranking in Healthcare

BeOne Medicines Ltd ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

17 lis 2025, 12:16 UTC

Major Market Movers

Zymeworks, Jazz Pharmaceuticals Shares Rise Following Positive Phase 3 Results for Cancer Treatment

DJ

Read

12 maj 2025, 02:16 UTC

Major Market Movers

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

DJ

Read

29 sty 2025, 15:59 UTC

Major Market Movers

ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene

DJ

Read

27 lis 2024, 15:22 UTC

Major Market Movers

BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment

DJ

Read

21 lis 2024, 14:45 UTC

Major Market Movers

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

DJ

Read

6 lis 2025, 11:01 UTC

Earnings

BeOne Medicines Sees FY25 Rev $5.1B-$5.3B >ONC

DJ

Read

6 lis 2025, 11:01 UTC

Earnings

BeOne Medicines 3Q Adj EPS $2.65 >ONC

DJ

Read

6 lis 2025, 11:01 UTC

Earnings

BeOne Medicines 3Q Rev $1.4B >ONC

DJ

Read

6 lis 2025, 11:00 UTC

Earnings

BeOne Medicines 3Q EPS $1.09 >ONC

DJ

Read

6 sie 2025, 10:01 UTC

Earnings

BeOne Medicines Narrows FY25 View To Rev $5.0B-$5.3B >ONC

DJ

Read

6 sie 2025, 10:01 UTC

Earnings

BeOne Medicines 2Q Rev $1.3B >ONC

DJ

Read

6 sie 2025, 10:01 UTC

Earnings

BeOne Medicines 2Q Adj EPS $2.25 >ONC

DJ

Read

6 sie 2025, 10:00 UTC

Earnings

BeOne Medicines 2Q EPS 84c >ONC

DJ

Read

9 lip 2025, 09:17 UTC

Hot Stocks

Stocks to Watch Wednesday: Freeport-McMoRan, Glencore, Novo Nordisk -- WSJ

DJ

Read

7 maj 2025, 10:07 UTC

Earnings

BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC

DJ

Read

7 maj 2025, 10:06 UTC

Earnings

BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC

DJ

Read

7 maj 2025, 10:05 UTC

Earnings

BeiGene 1Q Net $1.27M >ONC

DJ

Read

7 maj 2025, 10:04 UTC

Earnings

BeiGene Says to Rename Company to BeOne Medicines >ONC

DJ

Read

7 maj 2025, 10:02 UTC

Earnings

BeiGene 1Q EPS $0.00 >ONC

DJ

Read

7 maj 2025, 10:02 UTC

Earnings

BeiGene 1Q Rev Increased 49% >ONC

DJ

Read

7 maj 2025, 10:00 UTC

Earnings

BeiGene 1Q Rev $1.12B >ONC

DJ

Read

27 lut 2025, 11:07 UTC

Earnings

BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC

DJ

Read

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Global BRUKINSA Rev of $828M >ONC

DJ

Read

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Loss/Shr 11c >ONC

DJ

Read

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Rev $1.13B >ONC

DJ

Read

Peer Comparison

Price change

BeOne Medicines Ltd ADR Forecast

Price Target

By TipRanks

6.9% upside

12 Months Forecast

Average 391.06 USD  6.9%

High 424 USD

Low 362 USD

Based on 11 Wall Street analysts offering 12 month price targets forBeOne Medicines Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Based on 11 analysts giving stock ratings to BeOne Medicines Ltd ADR - Dist in the past 3 months.

Sentiment

By Acuity

152 / 374 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Operating profit

$

About BeOne Medicines Ltd ADR

BeiGene Ltd

Other stocks from the sector

LLY

Eli Lilly and Co.

1,021.76

↓-0.21%

JNJ

Johnson and Johnson

199.29

↑ +1.67%

ABBV

AbbVie Inc

233.81

↑ +0.62%

UNH

UnitedHealth Group Inc

320.41

↓-0.3%

AZN

AstraZeneca PLC ADR

89.34

↑ +0.22%
help-icon Live chat